Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer

Abstract Ovarian cancer (OC) is the most lethal gynecologic cancer due primarily to its asymptomatic nature and late stage at diagnosis. The development of non-invasive markers is an urgent priority. We report the accurate detection of epithelial OC using Artificial Intelligence (AI) and genome-wide...

Full description

Bibliographic Details
Main Authors: Ray O. Bahado-Singh, Amin Ibrahim, Zaid Al-Wahab, Buket Aydas, Uppala Radhakrishna, Ali Yilmaz, Sangeetha Vishweswaraiah
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-23149-1
_version_ 1798044524951371776
author Ray O. Bahado-Singh
Amin Ibrahim
Zaid Al-Wahab
Buket Aydas
Uppala Radhakrishna
Ali Yilmaz
Sangeetha Vishweswaraiah
author_facet Ray O. Bahado-Singh
Amin Ibrahim
Zaid Al-Wahab
Buket Aydas
Uppala Radhakrishna
Ali Yilmaz
Sangeetha Vishweswaraiah
author_sort Ray O. Bahado-Singh
collection DOAJ
description Abstract Ovarian cancer (OC) is the most lethal gynecologic cancer due primarily to its asymptomatic nature and late stage at diagnosis. The development of non-invasive markers is an urgent priority. We report the accurate detection of epithelial OC using Artificial Intelligence (AI) and genome-wide epigenetic analysis of circulating cell free tumor DNA (cfTDNA). In a prospective study, we performed genome-wide DNA methylation profiling of cytosine (CpG) markers. Both conventional logistic regression and six AI platforms were used for OC detection. Further, we performed Gene Set Enrichment Analysis (GSEA) analysis to elucidate the molecular pathogenesis of OC. A total of 179,238 CpGs were significantly differentially methylated (FDR p-value < 0.05) genome-wide in OC. High OC diagnostic accuracies were achieved. Conventional logistic regression achieved an area under the ROC curve (AUC) [95% CI] 0.99 [± 0.1] with 95% sensitivity and 100% specificity. Multiple AI platforms each achieved high diagnostic accuracies (AUC = 0.99–1.00). For example, for Deep Learning (DL)/AI AUC = 1.00, sensitivity = 100% and 88% specificity. In terms of OC pathogenesis: GSEA analysis identified ‘Adipogenesis’ and ‘retinoblastoma gene in cancer’ as the top perturbed molecular pathway in OC. This finding of epigenomic dysregulation of molecular pathways that have been previously linked to cancer adds biological plausibility to our results.
first_indexed 2024-04-11T23:05:39Z
format Article
id doaj.art-bb696cacbf2445b293e29499c0c4fa77
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T23:05:39Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-bb696cacbf2445b293e29499c0c4fa772022-12-22T03:58:02ZengNature PortfolioScientific Reports2045-23222022-11-011211910.1038/s41598-022-23149-1Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancerRay O. Bahado-Singh0Amin Ibrahim1Zaid Al-Wahab2Buket Aydas3Uppala Radhakrishna4Ali Yilmaz5Sangeetha Vishweswaraiah6Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of MedicineDepartment of Obstetrics and Gynecology, Beaumont Research InstituteDepartment of Obstetrics and Gynecology, Oakland University-William Beaumont School of MedicineDepartment of Care Management Analytics, Blue Cross Blue Shield of MichiganDepartment of Obstetrics and Gynecology, Oakland University-William Beaumont School of MedicineDepartment of Obstetrics and Gynecology, Oakland University-William Beaumont School of MedicineDepartment of Obstetrics and Gynecology, Beaumont Research InstituteAbstract Ovarian cancer (OC) is the most lethal gynecologic cancer due primarily to its asymptomatic nature and late stage at diagnosis. The development of non-invasive markers is an urgent priority. We report the accurate detection of epithelial OC using Artificial Intelligence (AI) and genome-wide epigenetic analysis of circulating cell free tumor DNA (cfTDNA). In a prospective study, we performed genome-wide DNA methylation profiling of cytosine (CpG) markers. Both conventional logistic regression and six AI platforms were used for OC detection. Further, we performed Gene Set Enrichment Analysis (GSEA) analysis to elucidate the molecular pathogenesis of OC. A total of 179,238 CpGs were significantly differentially methylated (FDR p-value < 0.05) genome-wide in OC. High OC diagnostic accuracies were achieved. Conventional logistic regression achieved an area under the ROC curve (AUC) [95% CI] 0.99 [± 0.1] with 95% sensitivity and 100% specificity. Multiple AI platforms each achieved high diagnostic accuracies (AUC = 0.99–1.00). For example, for Deep Learning (DL)/AI AUC = 1.00, sensitivity = 100% and 88% specificity. In terms of OC pathogenesis: GSEA analysis identified ‘Adipogenesis’ and ‘retinoblastoma gene in cancer’ as the top perturbed molecular pathway in OC. This finding of epigenomic dysregulation of molecular pathways that have been previously linked to cancer adds biological plausibility to our results.https://doi.org/10.1038/s41598-022-23149-1
spellingShingle Ray O. Bahado-Singh
Amin Ibrahim
Zaid Al-Wahab
Buket Aydas
Uppala Radhakrishna
Ali Yilmaz
Sangeetha Vishweswaraiah
Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
Scientific Reports
title Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
title_full Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
title_fullStr Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
title_full_unstemmed Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
title_short Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
title_sort precision gynecologic oncology circulating cell free dna epigenomic analysis artificial intelligence and the accurate detection of ovarian cancer
url https://doi.org/10.1038/s41598-022-23149-1
work_keys_str_mv AT rayobahadosingh precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT aminibrahim precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT zaidalwahab precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT buketaydas precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT uppalaradhakrishna precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT aliyilmaz precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer
AT sangeethavishweswaraiah precisiongynecologiconcologycirculatingcellfreednaepigenomicanalysisartificialintelligenceandtheaccuratedetectionofovariancancer